Subscribe to:
• POZ magazine • E-newsletters
POZ Personals Sign In / Join
Username:
 Password:
African American Hub News

Back to home » News & Views » Treatment News

 
August 29, 2008
SMART Study Findings on Abacavir and Cardiovascular Risk
August 28, 2008
PML Still a Risk and Often Progressive
August 27, 2008
Better HIV Treatment Response Seen in Older Patients
August 25, 2008
Cases of HIV Detectable in Semen, but Not Blood
August 22, 2008
New Drug Interaction Information With Reyataz
Non-Nukes and Triglyceride Levels Affect HDL Cholesterol
August 21, 2008
Short-term Therapy May Help HIV-Related Depression
August 20, 2008
Rapid Hep C Disease Progression in HIV-Positive Men
August 19, 2008
AIDS Activism For The Next Decade
Suicidal Thoughts Common in People With HIV
August 18, 2008
Antiretrovirals Diminish Artery Hardening
Vaccines: Lessons Learned
August 15, 2008
Milk Thistle Shows Potential for Hep C
Human Rights Struggles Define AIDS Fight
Norvir Tablets Similar to Capsules, Expected in 2009
PrEP: Preparing For Success?
August 14, 2008
New HIV Numbers: New Prevention Strategy? Part 1
New HIV Numbers: New Prevention Strategy? Part 2
Defining the Risk Factors for Kidney Damage in Patients Using Tenofovir
August 13, 2008
Encouraging Data From Second Tesamorelin Study for Lipo
Viread Receives Second Approval for Hep B Infection
August 12, 2008
Future Options for the Treatment Experienced
Isentress, Intelence and Prezista Combo Shines for Treatment Veterans
Studies Disagree on Abacavir for Patients With High Viral Loads
New Options for Those New to Treatment
August 11, 2008
Abacavir and Cardiovascular Risk: Is There or Isn’t There?
IDX899 Safe, Reduces Viral Load in Preliminary Study
August 08, 2008
Achieving Universal Treatment Access: The Experience in Rural Malawi
New NNRTI RDEA806 Shows Promise in Seven-Day Study
August 07, 2008
Abacavir and Heart Attack Risk: Round 2
Microbicides: Assessing Progress
Having Children a Priority for Many Positive Women
August 06, 2008
Isentress Continues to Show Well Versus Sustiva as First-Line Treatment
Hep C: The Other Epidemic
Stigma, Fear of Side Effects, Keep Many off Treatment
Sustiva Bests Kaletra for Treatment of Advanced HIV Disease
NNRTI Rilpivirine (TMC-278) Comparable to Sustiva in 96-Week Study
August 05, 2008
Report: Now Is Time to Prepare for PrEP
Some Gender and Racial Differences with Three Protease Inhibitors
August 04, 2008
Human Growth Hormone May Reduce Internal Fatty Deposits
Similar Survival Among IDUs on ARV Treatment
Shortage of Health Care Workers Threatens African HIV Care
IAC Panelists: Scale Up, Leadership and Youth Crucial to HIV Response
August 01, 2008
Discrimination Doesn’t Worsen Treatment Adherence

 

January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
 

Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Blogs by African-Americans
Antonia
Felipe		 JC Jeanette
Pinnace		 Kate
Ferguson

Read the blogs
Overheard in the Forums
"I'm HIV positive and diabetic (as well as have high cholesterol) and some of my meds specify taking them with 'high fat foods' which I have to do twice a day. I've eaten as healthy as possible, but when it comes to high fat foods, I am in a quandary...about what to eat sometimes..."

from Nutrition & HIV


Join the forums
Real Health Poll
Question: Do you know anyone who successfully quit smoking?
Yes
No
Smart + Strong Network
POZ Magazine
POZ Personals
POZ Mentor
POZ ASO Directory 		AIDSmeds
Real Health Magazine
TuSalud Magazine
ComboCards
Rx Info Cards
Also visit POZ on...
Facebook

 MySpace

 YouTube
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy